It is a healthcare private limited company based in Hyderabad, Telangana, India, established in 2014.
2014 | Hyderabad, Telangana, India | ActiveNyasa Pharma Private Limited, a active private limited company, was established on 08 January 2014 in Hyderabad, Telangana, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U24233TG2014PTC092228. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Kadiyala Venkata Naga Parvateesa Sai Chandra (Director), Sri Varshini Garimella (Director). Past directors included Kadiyala Ravi Kanth, Shaik Alli, Kadiyala Venkata Satya Narayana. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D.No:2-17-76/2/17, Raghavendra Nagar Colony, Kalyanapuri, Uppal, Hyderabad, Telangana, 500039.
U24233TG2014PTC092228
092228
08 January 2014
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Nyasa Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kadiyala Venkata Naga Parvateesa Sai Chandra | Director | 22 Nov 2018 | Current |
| Sri Varshini Garimella | Director | 17 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Nov 2020 | Past |
| Pramod Abcsdd | Director | 13 Nov 2015 | Past |
| Pramod Abcsdd | Director | 17 Jan 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nyasa Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 139.67% increase. The company also saw a substantial improvement in profitability, with a 258.05% increase in profit. The company's net worth Soared by an impressive increase of 35.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Nyasa Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Nyasa Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nyasa Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nyasa Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sri Varshini Garimella was appointed as a Director was appointed as a Director on 17 Jan 2025 & has been associated with this company since 11 months 7 days . was completed.
The activity Nyasa Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Nyasa Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Kadiyala Venkata Naga Parvateesa Sai Chandra was appointed as a Director was appointed as a Director on 22 Nov 2018 & has been associated with this company since 7 years 1 month . was recorded as a recent event.
The activity Nyasa Pharma Private Limited was registered on 08 Jan 2014 with Roc Hyderabad & aged 11 years 11 months as per MCA records. was completed.
The CIN of Nyasa Pharma Private Limited is U24233TG2014PTC092228.
Nyasa Pharma Private Limited is headquartered at D.No:2-17-76/2/17, Raghavendra Nagar Colony, Kalyanapuri, Uppal, Hyderabad, Telangana, 500039.
Nyasa Pharma Private Limited was incorporated on 08 January 2014.
The current directors of Nyasa Pharma Private Limited are
The primary industry of Nyasa Pharma Private Limited is Hospital And Medical Care.
Nyasa Pharma Private Limited is unlisted.
The authorized capital of Nyasa Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Nyasa Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX